1. Home
  2. Labeler Index
  3. Csl Behring Gmbh
  4. 63833-828
  5. Product Images: Haegarda C1 Esterase Inhibitor Subcutaneous (human)

Product Images Haegarda C1 Esterase Inhibitor Subcutaneous (human)

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 22 images provide visual information about the product associated with Haegarda C1 Esterase Inhibitor Subcutaneous (human) NDC 63833-828 by Csl Behring Gmbh, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1 - haegarda 01

Figure 1 - haegarda 01

Figure 2 - haegarda 02

Figure 2 - haegarda 02

Figure 3 - haegarda 03

Figure 3 - haegarda 03

Figure 4 - haegarda 04

Figure 4 - haegarda 04

Figure 5 - haegarda 05

Figure 5 - haegarda 05

Figure 6 - haegarda 06

Figure 6 - haegarda 06

Figure 7 - haegarda 07

Figure 7 - haegarda 07

Figure 8 - haegarda 08

Figure 8 - haegarda 08

Figure 9 - haegarda 09

Figure 9 - haegarda 09

Figure 10 - haegarda 10

Figure 10 - haegarda 10

Figure 11 - haegarda 11

Figure 11 - haegarda 11

Figure 12 - haegarda 12

Figure 12 - haegarda 12

PRINCIPAL DISPLAY PANEL - Kit Carton - 2000 IU - haegarda 13

PRINCIPAL DISPLAY PANEL - Kit Carton - 2000 IU - haegarda 13

PRINCIPAL DISPLAY PANEL - Kit Carton - 3000 IU - haegarda 14

PRINCIPAL DISPLAY PANEL - Kit Carton - 3000 IU - haegarda 14

haegarda 15

haegarda 15

haegarda 16

haegarda 16

haegarda 17

haegarda 17

haegarda 18

haegarda 18

haegarda 19

haegarda 19

haegarda 20

haegarda 20

haegarda 21

haegarda 21

HAEGARDA is a human product made from C1 Esterase Inhibitor and is intended for subcutaneous administration only. The manufacturer is CSL Behring located in Germany with a US office in Kings, USA. It should be stored in a refrigerator at a temperature of 2 to 25°C and should not be used after the expiry date. The rest of the document is not readable, possibly due to poor .*

haegarda 22

haegarda 22

HAEGARDA is a subcutaneous medication used for treating human asthma caused by C1 esterase inhibitor. Caution needs to be observed as per food safety warnings and precautions outlined in the section. Storage of the medicine must be done up to 30°C. The medicine should only be administered via subcutaneous injection. The rest of the text is not readable.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.